Study Stopped
Insufficient recruitment and not enough funding
Hyperpolarized 129Xe Magnetic Resonance Imaging for Evaluation of Radiation-Induced Lung Injury in Subjects Undergoing Thoracic Irradiation
RILI
Sponsor study identifier
observational
1
1 country
1
Study Start
September 1, 2018
Actual (reported)Primary Completion
November 1, 2019
Actual (reported)Study Completion
November 1, 2019
Actual (reported)The purpose of this work is to perform hyperpolarized (HP) 129Xe MRI in human subjects undergoing thoracic radiation therapy (RT), both before, during and following RT. HP 129Xe MR images will be analysed to provide maps of ventilation (V), perfusion (Q), apparent diffusion coefficient (ADC) and gas exchange. These results will be combined to yield a new measure of RILI, (i.e. dose volume histograms; DVHV/Q) and compared with conventional dose volume histograms (DVH), pulmonary function tests (PFTs), quality of life (QOL) questionnaire and CT measurements for assessment of RILI at each time point. The aim is to development a novel method for early and more sensitive method of detecting RILI before irreversible lung damage happens.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 1, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 7, 2018
Actual (reported)February 13, 2018
Actual (reported)September 1, 2018
Actual (reported)November 1, 2019
Actual (reported)November 1, 2019
Actual (reported)DVHV/Q
In-house software will be used to generate the ventilation, perfusion and gas exchange maps and calculate DVHV/Q
2 years
Lung MRI for participants undergoing radiation therapy (RT)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Participant will be recruited from Princess Margaret Hospital, Toronto, Ontario and Juravinski Cancer Centre, Hamilton, Ontario.
Contact the study team to confirm eligibility.
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Giles Santyr, PhD
The Hospital for Sick Children
1 participants (actual enrollment reported by the registry).
First Submitted
February 7, 2018
First Posted
February 13, 2018
Study Start
September 1, 2018
Actual (reported)Primary Completion
November 1, 2019
Actual (reported)Study Completion
November 1, 2019
Actual (reported)Last Updated
August 1, 2025
Record last verified: 2025-07
Data will be shared between the three participating sites in the study. A data transfer agreement has been implemented to enable this transfer smoothly.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: